5 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
and CKD EMPA-REG ... outcomes in HFrEF on GDMT ... outcomes in HFrEF on GDMT ... visualabstract #table ... #CVD #CKD
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... -4 inhibitors SGLT2 ... Improved outcomes in CKD ... #table #comparison
Guideline-Directed Medical Therapy (GDMT) in HFrEF and CKD

 • Class I pillars of HFrEF GDMT across
) in HFrEF and CKD ... diuretics, MRA, SGLT2i ... after core GDMT ... Chronotropes • Medications ... #CKD #HFrEF #management
Drugs Used in Coronary Artery Disease 
 • Nitrates
 • Ca2+ Channel Blockers
 • Beta-Blockers
 •
Used in Coronary Artery ... #coronary #artery ... #disease #CAD # ... medications #drugs ... #pharmacology #table
Causes of Secondary Hypertension - Workup and Differential Diagnosis
Approach (when evaluation should be done):
1. Severe or
with previously stable ... Vascular: Renal artery ... parenchymal disease: CKD ... Differential #Diagnosis #indications